Walking Interventions, cognitive remediation and mild cognitive impairment
Walking Interventions, cognitive remediation and mild cognitive impairment
批准号:
8399456
负责人:
Jeffrey Neil Keller
金额:
$22.2万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-30 至 2014-06-30
关键词:
Alzheimer&aposs DiseaseAreaClinicalClinical ResearchClinical Trials DesignCognitionCognitiveCognitive remediationConflict (Psychology)DataData SetDatabasesDementiaDevelopmentElderlyEquilibriumExhibitsExperimental DesignsFall preventionFundingFutureGaitGeriatricsImpaired cognitionIndividualInterventionLaboratoriesLengthLifeLinkLiteratureLower ExtremityMeasuresMental DepressionMonitorNeurosciences ResearchParticipantPerformancePhysical activityProcessPublicationsRandomizedRandomized Clinical TrialsRegimenRegistriesReportingReproducibilityResearchResearch DesignResourcesShort-Term MemorySpeedStandardizationTechnologyTestingTherapeuticTherapeutic InterventionTrainingUnited States National Institutes of HealthUrsidae FamilyVisitWalkingage effectarmcognitive changecognitive functiondesignefficacy trialexperiencefall riskfallsfrailtygeriatric depressionimprovedinsightinterestlifestyle interventionmental statemild neurocognitive impairmentnormal agingpre-clinicalprocessing speedprogramsstandard measure
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal outlines a tightly controlled efficacy trial designed to elucidate the potential therapeutic benefit of a walking intervention (WI), cognitive remediation therapy (CRT), as well as combined WI and CRT program towards specific aspects of gait and cognition in individuals with mild cognitive impairment (MCI). These studies are important clinically because they provide the framework for the implementation of a therapeutic program in the future which reduces falls and prevents/delays the development of dementia in the elderly. The design of the studies in this proposal significantly advance the field by providin much needed clarity to a research area that contains conflicting data on the reliability, reproducibility, robustness, and sustainability of the therapeutic benefit conferred by WI and CRT. To our knowledge this is the first study to examine the individual, and combined, effects of WI and CRT (particularly in the context of MCI). Our experimental design will contribute to the process of elucidating the mechanism(s) responsible for promoting the beneficial effects of WI and/or CRT, and contribute to designing the most effective therapeutic program in the future. Scientifically these studies are important because there is increasing interest in understanding the potential interactions between gait changes and cognitive decline during the development of dementia, and these studies are designed to examine the effects of each intervention towards cognition as well as multiple aspects of gait, under both laboratory and free-living conditions. The focus of this proposal is to test the hypothesis that implementation of a WI, CRT, or a combined WI/CRT program, will have significant and beneficial effects towards cognition and gait in elderly individuals with MCI. Additionally, we will test the related hypothesis that the combined WI/CRT program will provide synergistic benefit compared to the delivery of either WI or CRT alone. In Specific Aim 1 we will determine the effects of each intervention towards multiple gait parameters under both laboratory and free living conditions. In Specific Aim 2 we will determine the effects of each intervention towards multiple aspects of cognition. The current proposal brings to bear many of the latest technological advances, diverse clinical expertise, a powerful clinical registry, and strong clinical resources in order to understand the effects of a W, CRT, and a combined WI/CRT program using a randomized clinical trial approach. These efforts are a necessary first step for the eventual development of a therapeutic program that reduces falls/dementia in the elderly, and will significantly contribute to the understanding of th shared and selective effects of aging towards gait and cognitive decline.
PUBLIC HEALTH RELEVANCE: This is a tightly controlled efficacy trial designed to understand the effects of a walking intervention, cognitive remediation therapy, and combined walking and cognitive remediation program towards aspects of dementia and fall risk in individuals with mild cognitive impairment. These findings will provide insight to links between cognitive function and gait, and have a significant impact in clinical research areas of dementia, geriatrics, frailty, lifestyle interventions, and neuroscience research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Walking Interventions, cognitive remediation and mild cognitive impairment
-
批准号:8540344
-
项目类别:
-
资助金额:$17.95万
-
财政年份:2012
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary and Visceral Fat Regulate Vascular Amyloid Pathogenesis
-
批准号:8245332
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2011
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary and Visceral Fat Regulate Vascular Amyloid Pathogenesis
-
批准号:8326042
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2011
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary restriction and proteasome-mediated protein degradation in the aging CNS
-
批准号:8124882
-
项目类别:
-
资助金额:$28.1万
-
财政年份:2007
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary restriction, aging, and the proteasome
-
批准号:7895562
-
项目类别:
-
资助金额:$23.75万
-
财政年份:2007
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary restriction, aging, and the proteasome
-
批准号:7559080
-
项目类别:
-
资助金额:$21.57万
-
财政年份:2007
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary restriction and proteasome-mediated protein degradation in the aging CNS
-
批准号:7917433
-
项目类别:
-
资助金额:$26.31万
-
财政年份:2007
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary restriction and proteasome-mediated protein degradation in the aging CNS
-
批准号:7675996
-
项目类别:
-
资助金额:$26.58万
-
财政年份:2007
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary restriction and proteasome-mediated protein degradation in the aging CNS
-
批准号:7564171
-
项目类别:
-
资助金额:$27.13万
-
财政年份:2007
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary restriction, aging, and the proteasome
-
批准号:7666085
-
项目类别:
-
资助金额:$26.65万
-
财政年份:2007
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary restriction, aging, and the proteasome
-
批准号:7472437
-
项目类别:
-
资助金额:$26.65万
-
财政年份:2007
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary restriction, aging, and the proteasome
-
批准号:7147670
-
项目类别:
-
资助金额:$5.53万
-
财政年份:2007
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary restriction and proteasome-mediated protein degradation in the aging CNS
-
批准号:7487373
-
项目类别:
-
资助金额:$29.53万
-
财政年份:2007
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary restriction and proteasome-mediated protein degradation in the aging CNS
-
批准号:7242874
-
项目类别:
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:Jeffrey Neil Keller
-
依托单位:
Dietary restriction, aging, and the proteasome
-
批准号:8113229
-
项目类别:
-
资助金额:$22.82万
-
财政年份:2007
-
负责人:Jeffrey Neil Keller
-
依托单位:
Genetic basis for alpha-synuclein toxicity
-
批准号:7093277
-
项目类别:
-
资助金额:$16.48万
-
财政年份:2006
-
负责人:Jeffrey Neil Keller
-
依托单位:
Genetic basis for alpha-synuclein toxicity
-
批准号:7230194
-
项目类别:
-
资助金额:$4.86万
-
财政年份:2006
-
负责人:Jeffrey Neil Keller
-
依托单位:
Genetic basis for alpha-synuclein toxicity
-
批准号:7613729
-
项目类别:
-
资助金额:$11.14万
-
财政年份:2006
-
负责人:Jeffrey Neil Keller
-
依托单位:
Proteasome Inhibition in Brain Aging
-
批准号:6370377
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2001
-
负责人:Jeffrey Neil Keller
-
依托单位:
Proteasome Inhibition in Brain Aging
-
批准号:6640930
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2001
-
负责人:Jeffrey Neil Keller
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: